Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾ÏÀÇ ¿ø¹ß Á¾¾ç ¹× ÀüÀÌ ¸²ÇÁÀýÀÇ p53 º¯À̾ç»ó ¹× MIB-1 Index ºñ±³ Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer

´ëÇÑ¿Ü°úÇÐȸÁö 2001³â 61±Ç 4È£ p.364 ~ 372
¹Î¿¬±â, Á¶¼ºÁø, ±è³²·Ä, Á¶¹Î¿µ, Á¤¼®ÀÎ, ¹èÁ¤¿ø, ¿ø³²Èñ, ¼­¼º¿Á, ±è¿µÃ¶, ±¸¹üȯ, ȲÁ¤¿õ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Î¿¬±â ( Min Youn-Ki ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Á¶¼ºÁø ( Cho Seong-Jin ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è³²·Ä ( Kim Nam-Ryeol ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Á¶¹Î¿µ ( Cho Min-Young ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Á¤¼®ÀΠ( Jung Suk-In ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹èÁ¤¿ø ( Bae Jung-Won ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¿ø³²Èñ ( Won Nam-Hee ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼­¼º¿Á ( Seo Seong-Ok ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è¿µÃ¶ ( Kim Young-Chul ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±¸¹üȯ ( Koo Bum-Hwan ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ȲÁ¤¿õ ( Whang Jeong-Woong ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose : This study was designed to elucidate the biology of cancer metastasis and differences in the biologic status between primary tumors and metastatic lymph nodes of invasive breast cancer by comparing the well known prognostic
factors
p53
gene mutation, p53 protein expression and the MIB-1 index. An additional goal was to investigate the p53 mutational pattern of breast cancer patients.
Methods : We used the PCR-SSCP method to detect p53 gene mutation and immunohistochemical staining to establish p53 protein expression and the MIB-1 labelling index in 25 primary tumors and metastatic lymph nodes from breast cancer
patients.
We
then made a comparison the between primary tumors and the metastatic lymph nodes.
Results : The results indicated a correlation between histologic grade and p53 gene mutation as well as p53 protein expression, but showed no correlation to MIB-1 labelling index. The concordance rates of p53 gene mutation and p53 protein
expression between the primary tumors and metastatic lymph nodes were 72% and 100%, respectively. Three cases showed a different mutated exon number between the primary tumors and the metastatic lymph nodes. Some cases showed p53 gene mutation
only
in
the primary tumors, but while other cases only in the metastatic lymph nodes. The MIB-1 labelling index increased with tumor grade. The p53 altered group show a higher mean MIB-1 index than the non altered group¡¯s in both the primary tumors and
metastatic lymph nodes.
Conclusion : p53 gene mutation is not consistent with p53 protein expression and there are some differences in p53 gene mutation between primary tumors and metastatic lymph nodes in breast cancer. Therefore, metastatic tumor have different
characteristics from those of primary tumors. In breast cancer, metastasis is regulated not only by an up- regulating mechanism but also by a down-regulating mechanism.

Å°¿öµå

À¯¹æ¾Ï; p53 À¯ÀüÀÚ º¯ÀÌ; p53 ´Ü¹é¹ßÇö; MIB-1 index; Breast cancer; p53 gene mutation; p53 protein expression; MIB-1 index;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS